Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
<h4>Background</h4>In non-small cell lung cancer (NSCLC), PD-L1 expression on either tumor cells (TC) or both TC and tumor-infiltrating immune cells (IC) is currently the most used biomarker in cancer immunotherapy. However, the mechanisms involved in PD-L1 regulation are not fully under...
Main Authors: | Willemijn S M E Theelen, Thomas Kuilman, Katja Schulze, Wei Zou, Oscar Krijgsman, Dennis D G C Peters, Sten Cornelissen, Kim Monkhorst, Pranamee Sarma, Teiko Sumiyoshi, Lukas C Amler, Stefan M Willems, Johannes L G Blaauwgeers, Carel J M van Noesel, Daniel S Peeper, Michel M van den Heuvel, Marcin Kowanetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0216864 |
Similar Items
-
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma
by: W. S. M. E. Theelen, et al.
Published: (2020-07-01) -
Phenotypic diversity drives paracrine drug tolerance
by: Thomas Kuilman, et al.
Published: (2017-07-01) -
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas
by: Richard J. Bende, et al.
Published: (2009-08-01) -
SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
by: Sofía Ibáñez-Molero, et al.
Published: (2022-12-01) -
Gene expression profile of AIDS-related Kaposi's sarcoma
by: van Noesel Carel JM, et al.
Published: (2003-03-01)